Education
About Us
Working with TipRanks
Follow Us
DarioHealth Corp (DRIO)
NASDAQ:DRIO
DRIO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.38 - $1.55
Previous CloseN/A
Volume780.96K
Average Volume (3M)191.68K
Market Cap
$20.02M
Enterprise Value$42.70M
Total Cash (Recent Filing)$22.17M
Total Debt (Recent Filing)$31.62M
Price to Earnings (P/E)―
Beta1.47
Next Earnings
Nov 17, 2025EPS Estimate
-0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.18
Shares Outstanding45,496,956
10 Day Avg. Volume233,585
30 Day Avg. Volume191,682
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap2.13
Enterprise Value/Revenue1.57
Enterprise Value/Gross Profit2.86
Enterprise Value/Ebitda-1.12
Forecast
1Y Price Target
$0.93Price Target Upside69.09% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Bulls Say, Bears Say
Bulls Say
Client AcquisitionThe company noted two new major health plan clients, with one scheduled to launch in the second half of 2025, bringing their total clients signed year-to-date to 21.
Growth OpportunitiesManagement quantified their pipeline at $53 million, with $5 million being in an advanced stage, indicating potential growth opportunities.
Revenue GrowthDRIO highlighted two key wins: a large national health plan and a large US insurance company, both expected to contribute to revenue in the second half.
Bears Say
Contract RenewalA significant contract expiration contributed to the revenue miss and is pending renewal.
Financial GuidanceDarioHealth subsequently cut its breakeven cash flow guidance from the end of 2025 to the end of 2026 or early 2027.
Revenue MissThe 2Q headline numbers were disappointing, with revenue and EBITDA coming in substantially below estimates.
DarioHealth News
DRIO FAQ
What was DarioHealth Corp’s price range in the past 12 months?
DarioHealth Corp lowest stock price was $0.38 and its highest was $1.55 in the past 12 months.
What is DarioHealth Corp’s market cap?
DarioHealth Corp’s market cap is $20.02M.
When is DarioHealth Corp’s upcoming earnings report date?
DarioHealth Corp’s upcoming earnings report date is Nov 17, 2025 which is in 86 days.
How were DarioHealth Corp’s earnings last quarter?
DarioHealth Corp released its earnings results on Aug 12, 2025. The company reported -$0.18 earnings per share for the quarter, beating the consensus estimate of -$0.233 by $0.053.
Is DarioHealth Corp overvalued?
According to Wall Street analysts DarioHealth Corp’s price is currently Undervalued.
Does DarioHealth Corp pay dividends?
DarioHealth Corp does not currently pay dividends.
What is DarioHealth Corp’s EPS estimate?
DarioHealth Corp’s EPS estimate is -0.24.
How many shares outstanding does DarioHealth Corp have?
DarioHealth Corp has 45,496,956 shares outstanding.
What happened to DarioHealth Corp’s price movement after its last earnings report?
DarioHealth Corp reported an EPS of -$0.18 in its last earnings report, beating expectations of -$0.233. Following the earnings report the stock price went down -14%.
Which hedge fund is a major shareholder of DarioHealth Corp?
Currently, no hedge funds are holding shares in DRIO
DarioHealth Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$0.93 (69.09% Upside)
$0.93 (69.09% Upside)
Blogger Sentiment
Bullish
DRIO Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 313.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▲ 2.3%
Last 30 Days ▲ 2.3%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-53.04%
12-Months-Change
Fundamentals
Return on Equity
-55.06%
Trailing 12-Months
Asset Growth
-11.31%
Trailing 12-Months
Company Description
DarioHealth Corp
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
DRIO Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlights DarioHealth's strong client acquisition, improved gross margins, and strategic partnerships, indicating a solid foundation for future growth. However, the revenue decline, delayed cash flow breakeven, and loss of a significant contract present notable challenges. Despite these setbacks, the company's strategic focus on AI and operational efficiency provides a positive outlook for recovery and growth.View all DRIO earnings summariesDRIO Stock 12 Month Forecast
Average Price Target
$0.93
▲(69.09% Upside)
Technical Analysis
Ownership Overview
6.78% Insiders
1.44% Mutual Funds
12.46% Other Institutional Investors
78.57% Public Companies and
Individual Investors